Johnson & Johnson Target Price

See Johnson & Johnson's analyst price targets ($280) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$266.32

Average Target Price

$284.68

6.9% upside

19 analysts in the last 4 months

High: $320 | Low: $260

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-10	HSBC	$320	20.2% upside
2026-09-02	UBS	$320	20.2% upside
2026-08-06	Guggenheim	$287	7.8% upside
2026-08-03	Wells Fargo	$282	5.9% upside
2026-08-03	Raymond James	$280	5.1% upside
2026-07-29	Argus ResearchDavid Toung	$300	12.6% upside
2026-07-16	Johnson RiceIlya Zubkov	$280	5.1% upside
2026-07-16	Wells Fargo	$272	2.1% upside
2026-07-16	Morgan StanleyTerence Flynn	$294	10.4% upside
2026-07-16	Johnson Rice	$261	2% downside
2026-07-16	Goldman Sachs	$282	5.9% upside
2026-07-16	Scotiabank	$305	14.5% upside
2026-07-16	Raymond James	$265	0.5% downside
2026-07-15	Stifel NicolausRick Wise	$260	2.4% downside
2026-07-13	RBC Capital	$287	7.8% upside
2026-07-08	Morgan StanleyTerence Flynn	$284	6.6% upside
2026-07-06	HSBC	$290	8.9% upside
2026-06-26	GuggenheimVamil Divan	$270	1.4% upside
2026-06-26	Johnson Rice	$270	1.4% upside
2026-05-13	Leerink PartnersDavid Risinger	$265	0.5% downside
2026-04-20	Guggenheim	$266	0.1% downside
2026-04-15	Stifel NicolausRick Wise	$250	6.1% downside
2026-04-15	Morgan Stanley	$283	6.3% upside
2026-04-15	BarclaysMatt Miksic	$255	4.3% downside
2026-04-15	RBC Capital	$265	0.5% downside
2026-04-10	Morgan Stanley	$267	0.3% upside
2026-03-18	Morgan Stanley	$253	5% downside
2026-02-03	RBC Capital	$255	4.3% downside
2026-01-28	Morgan StanleyTerrance Flynn	$262	1.6% downside
2026-01-27	Loop Capital MarketsIlya Zubkov	$220	17.4% downside
2026-01-23	GuggenheimVamil Divan	$240	9.9% downside
2026-01-22	Morgan StanleyTerence Flynn	$200	24.9% downside
2026-01-22	Wells Fargo	$240	9.9% downside
2026-01-22	Scotiabank	$265	0.5% downside
2026-01-22	Goldman SachsAsad Haider	$250	6.1% downside
2026-01-22	Stifel NicolausRick Wise	$220	17.4% downside
2026-01-09	BernsteinLee Hambright	$208	21.9% downside
2025-12-30	BarclaysMatt Miksic	$217	18.5% downside
2025-12-18	Goldman SachsAsad Haider	$240	9.9% downside
2025-12-17	RBC Capital	$240	9.9% downside
2025-12-12	Morgan Stanley	$197	26% downside
2025-12-11	RBC Capital	$230	13.6% downside
2025-12-10	HSBC	$240	9.9% downside
2025-12-05	Guggenheim	$227	14.8% downside
2025-12-02	Barclays	$197	26% downside
2025-10-22	Johnson RiceIlya Zubkov	$190	28.7% downside
2025-10-22	Loop Capital MarketsIlya Zubkov	$190	28.7% downside
2025-10-15	Morgan StanleyTerence Flynn	$190	28.7% downside
2025-10-15	Raymond James	$209	21.5% downside
2025-10-15	Argus ResearchDavid Toung	$210	21.1% downside

Johnson & Johnson (JNJ) FAQ

The latest target price for JNJ is $280. Investors often review this figure alongside Johnson & Johnson's historical trend and sector peers before judging valuation or financial health.

Johnson & Johnson trades near $266.32 while the consensus target sits at $280 (6.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting JNJ's target price ($280), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Johnson & Johnson's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.